Skip to content
Screener

Shattuck Labs, Inc. STTK Interest Income

Interest Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$219M-15.8%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1.76M-12.7%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$3.65M-38.4%
Vor Biopharma logo
Vor BiopharmaVOR
$3.94M+389%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$2.66M-40.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$8.49M+29.7%

Segments

By segment

See full
Reportable Segment$2.7M-47.8%

Other financials

Income statement

See full
Revenue-
Operating income-$16.2M-24.0%
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
Operating cash flow-$10.2M+2.4%
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$694.34M+1,861%
Enterprise value$633.72M-5,344%
P/S694.3×+683×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 6:57 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055483
RevenueThree Months Ended June 30, 2026 / $Three Months Ended June 30, 2026 / —Three Months Ended June 30, 2025 / $Three Months Ended June 30, 2025 / —Six Months Ended June 30, 2026 / $Six Months Ended June 30, 2026 / —Six Months Ended June 30, 2025 / $Six Months Ended June 30, 2025 / —
Expense from operations16,15513,03231,69927,421
Loss from operations(16,155)(13,032)(31,699)(27,421)
Other income (expense)
Interest income1,0298041,8321,416
Other expense(26)(230)(52)(155)
Total other income1,0035741,7801,261
Net loss$$(15,152)$$(12,458)$$(29,919)$$(26,160)
Unrealized (loss) gain on investments(63)1(69)(1)

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s interest income?
Shattuck Labs, Inc. (STTK) reported interest income of $1.03M in Q2 2026.
How has Shattuck Labs, Inc.'s interest income changed year-over-year?
Shattuck Labs, Inc.'s interest income increased by 28.0% year-over-year, from $804K to $1.03M.
What is the long-term trend for Shattuck Labs, Inc.'s interest income?
Over 2 years (2022 to 2024), Shattuck Labs, Inc.'s interest income has grown at a 80.3% compound annual growth rate (CAGR), from $1.59M to $5.17M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Shattuck Labs, Inc.'s interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude